201 related articles for article (PubMed ID: 14647145)
1. An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue.
Abe N; Watanabe T; Suzuki Y; Matsumoto N; Masaki T; Mori T; Sugiyama M; Chiappetta G; Fusco A; Atomi Y
Br J Cancer; 2003 Dec; 89(11):2104-9. PubMed ID: 14647145
[TBL] [Abstract][Full Text] [Related]
2. HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma.
Hristov AC; Cope L; Reyes MD; Singh M; Iacobuzio-Donahue C; Maitra A; Resar LM
Mod Pathol; 2009 Jan; 22(1):43-9. PubMed ID: 18843278
[TBL] [Abstract][Full Text] [Related]
3. HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma.
Piscuoglio S; Zlobec I; Pallante P; Sepe R; Esposito F; Zimmermann A; Diamantis I; Terracciano L; Fusco A; Karamitopoulou E
Histopathology; 2012 Feb; 60(3):397-404. PubMed ID: 22276603
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of high mobility group A2 (HMGA2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic HMGA2 expression.
Gundlach JP; Hauser C; Schlegel FM; Willms A; Halske C; Röder C; Krüger S; Röcken C; Becker T; Kalthoff H; Trauzold A
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3313-3324. PubMed ID: 34302528
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins.
Abe N; Watanabe T; Masaki T; Mori T; Sugiyama M; Uchimura H; Fujioka Y; Chiappetta G; Fusco A; Atomi Y
Cancer Res; 2000 Jun; 60(12):3117-22. PubMed ID: 10866296
[TBL] [Abstract][Full Text] [Related]
6. Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC.
Strell C; Norberg KJ; Mezheyeuski A; Schnittert J; Kuninty PR; Moro CF; Paulsson J; Schultz NA; Calatayud D; Löhr JM; Frings O; Verbeke CS; Heuchel RL; Prakash J; Johansen JS; Östman A
Br J Cancer; 2017 Jun; 117(1):65-77. PubMed ID: 28524160
[TBL] [Abstract][Full Text] [Related]
7. KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas.
Yantiss RK; Woda BA; Fanger GR; Kalos M; Whalen GF; Tada H; Andersen DK; Rock KL; Dresser K
Am J Surg Pathol; 2005 Feb; 29(2):188-95. PubMed ID: 15644775
[TBL] [Abstract][Full Text] [Related]
8. Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours.
Franco R; Esposito F; Fedele M; Liguori G; Pierantoni GM; Botti G; Tramontano D; Fusco A; Chieffi P
J Pathol; 2008 Jan; 214(1):58-64. PubMed ID: 17935122
[TBL] [Abstract][Full Text] [Related]
9. HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias.
Chiappetta G; Ferraro A; Vuttariello E; Monaco M; Galdiero F; De Simone V; Califano D; Pallante P; Botti G; Pezzullo L; Pierantoni GM; Santoro M; Fusco A
Eur J Cancer; 2008 May; 44(7):1015-21. PubMed ID: 18375116
[TBL] [Abstract][Full Text] [Related]
10. MiR-590 Suppresses Proliferation and Induces Apoptosis in Pancreatic Cancer by Targeting High Mobility Group A2.
Wang YD; Mao JD; Wang JF; Xu MQ
Technol Cancer Res Treat; 2020; 19():1533033820928143. PubMed ID: 32588766
[TBL] [Abstract][Full Text] [Related]
11. Gene expression alterations in the non-neoplastic parenchyma adjacent to infiltrating pancreatic ductal adenocarcinoma.
Fukushima N; Koopmann J; Sato N; Prasad N; Carvalho R; Leach SD; Hruban RH; Goggins M
Mod Pathol; 2005 Jun; 18(6):779-87. PubMed ID: 15791284
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cyst fluid concentration of high-mobility group A2 protein acts as a differential biomarker of dysplasia in intraductal papillary mucinous neoplasm.
DiMaio CJ; Weis-Garcia F; Bagiella E; Tang LH; Allen PJ
Gastrointest Endosc; 2016 Jun; 83(6):1205-9. PubMed ID: 26408423
[TBL] [Abstract][Full Text] [Related]
13. New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8.
Karanjawala ZE; Illei PB; Ashfaq R; Infante JR; Murphy K; Pandey A; Schulick R; Winter J; Sharma R; Maitra A; Goggins M; Hruban RH
Am J Surg Pathol; 2008 Feb; 32(2):188-96. PubMed ID: 18223320
[TBL] [Abstract][Full Text] [Related]
14. Chondroitin sulfate proteoglycan CSPG4 as a novel hypoxia-sensitive marker in pancreatic tumors.
Keleg S; Titov A; Heller A; Giese T; Tjaden C; Ahmad SS; Gaida MM; Bauer AS; Werner J; Giese NA
PLoS One; 2014; 9(6):e100178. PubMed ID: 24932730
[TBL] [Abstract][Full Text] [Related]
15. [Expression and clinical significance of HMGA2 in renal carcinoma].
Liu Y; Fu QZ; Pu L; Song LL; Lyu GY; Liu J; Wang Z; Wang Z
Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):127-132. PubMed ID: 28219208
[No Abstract] [Full Text] [Related]
16. LIV-1 enhances the aggressive phenotype through the induction of epithelial to mesenchymal transition in human pancreatic carcinoma cells.
Unno J; Satoh K; Hirota M; Kanno A; Hamada S; Ito H; Masamune A; Tsukamoto N; Motoi F; Egawa S; Unno M; Horii A; Shimosegawa T
Int J Oncol; 2009 Oct; 35(4):813-21. PubMed ID: 19724917
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-32 expression in the pancreas.
Nishida A; Andoh A; Inatomi O; Fujiyama Y
J Biol Chem; 2009 Jun; 284(26):17868-76. PubMed ID: 19386602
[TBL] [Abstract][Full Text] [Related]
18. HMGA2 overexpression in non-small cell lung cancer.
Meyer B; Loeschke S; Schultze A; Weigel T; Sandkamp M; Goldmann T; Vollmer E; Bullerdiek J
Mol Carcinog; 2007 Jul; 46(7):503-11. PubMed ID: 17477356
[TBL] [Abstract][Full Text] [Related]
19. Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice.
Ohuchida K; Mizumoto K; Ohhashi S; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Int J Cancer; 2007 Apr; 120(8):1634-40. PubMed ID: 17236203
[TBL] [Abstract][Full Text] [Related]
20. MiR-497 inhibits cell proliferation and invasion ability by targeting HMGA2 in pancreatic ductal adenocarcinoma.
Zhou ZG; Xu C; Dong Z; Wang YP; Duan JY; Yan CQ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):122-129. PubMed ID: 31957824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
